Login / Signup

Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells.

Rachel ThijssenSilvia Alvarez-DiazClea GraceMing-Yuan GaoDavid H SegalZhen XuAndreas StrasserDavid Ching Siang Huang
Published in: Cell death and differentiation (2020)
Keyphrases
  • drug induced
  • liver injury
  • induced apoptosis
  • cell cycle arrest
  • diffuse large b cell lymphoma
  • transcription factor
  • adverse drug
  • oxidative stress
  • cell death